Adalimumab vs Bordetella Pertussis Toxin

## Adalimumab vs Bordetella Pertussis Toxin: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Bordetella Pertussis Toxin**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Bordetella Pertussis Toxin — N/A.

## Chemical Properties

**Type**: Adalimumab — Antibody; Bordetella Pertussis Toxin — Vaccine component.